Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial

NCT05237947 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

5000

Enrollment

NIH

Sponsor class

Conditions

Human Papillomavirus-Related Cervical Carcinoma

Interventions

BIOLOGICAL: Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
OTHER: Questionnaire Administration
BIOLOGICAL: Recombinant Human Papillomavirus Bivalent Vaccine
BIOLOGICAL: Recombinant Human Papillomavirus Nonavalent Vaccine

Sponsor

National Cancer Institute (NCI)